Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as alternatives to, financial measures prepared in accordance with GAAP.

Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as alternatives to, financial measures prepared in accordance with GAAP.

Our Responsibility All Avient officers, associates, and third parties acting on behalf of Avient are responsible for understanding and complying with this Policy and each of them has an obligation to: • Be familiar with applicable aspects of the Policy and communicate them to subordinates • Ask questions if the Policy or action required to be taken in a particular situation is unclear • Properly manage and monitor business activities conducted through third parties • Be alert to indications or evidence of possible wrongdoing • Promptly report violations or suspected violations through appropriate channels ABAC Laws make it unlawful for any company or person to offer, promise, pay or authorize the payment of anything of value to any individual2 to help keep or secure business or obtain some other improper business advantage. subject= http://avient.ethicspoint.com 5 Quick Reference: ABAC DOs AND DON’Ts DO ✓ Know that Avient prohibits any form of bribery and corruption and does not allow facilitation payments ✓ Be familiar with applicable aspects of our ABAC Policies and communicate them to subordinates and third parties ✓ Ask questions if the Policies or actions required to be taken are unclear ✓ Promptly report violations or suspected violations to your supervisor, the Legal Department or the Ethics Hotline ✓ Know that “value” is not necessarily measured in monetary terms ✓ Know that bribes can include the following: • Cash and cash equivalents (gift cards or gift certificates) • Gifts, entertainment and hospitality where there is no clear business purpose or they are in excess of business needs • Payment of travel expenses or vacations • Paying a government official to ignore an applicable customs requirement or to accelerate a tax refund • Personal services, favors, and loans • Offers of employment or other benefits to a family member or friend of the individual who has influence • Political party and candidate contributions • Charitable donations and sponsorships • Other less obvious items include in-kind contributions, investment opportunities and favorable or steered subcontracts ✓ Know that the prohibition applies whether an item would benefit the individual directly or another person, such as a family member, friend or business associate ✓ Keep books, records, and accounts in reasonable detail, and accurately and fairly reflect the transaction ✓ Conduct due diligence on agents, distributors, and other third parties prior to engagement and during the relationship and obtain Legal Department approval ✓ Properly manage and monitor business activities conducted through third-parties DON’T x Offer, promise, pay, or authorize the payment of anything of value to any government official and/or private sector employees to help Avient obtain or keep business or secure some other improper business advantage. Francisco Nakasato, 1700 13295-000 Itupeva Sao Paulo, Brazil Telephone: +55 11 4593 9200 Europe Pommerloch, Luxembourg 19 Route de Bastogne Pommerloch, Luxembourg, L-9638 Telephone: +352 269 050 35 Fax: +352 269 050 45 www.avient.com http://www.avient.com

Mevopur™ Healthcare Colorants and Formulations: a range of medical grade concentrates and pre-colored formulations for a wide range of polymers used in applications such as remote patient monitoring, circulating blood contact, and invasive devices, with pre-tested biocompatibility according to ISO 10993, change control in place, production certified to ISO 13485-2016 and DMF/MAF files available

PolyOne’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of the Company and each business segment and to allocate resources. T H E N E W P O L Y O N E : A S P E C I A L T Y G R O W T H C O M P A N Y  Growing leadership position in attractive markets  Innovation, technology and service are differentiators  Capital management is a strength: Record-setting cash generation to continue for years  Expand ROIC while increasing invested capital  Proven acquisition strategy with robust pipeline  Commercial investments are fueling momentum and generating organic growth SERVICE: T H E T I M E L E S S D I F F E R E N T I A T O R PolyOne Corporation 28 T A L E N T D E V E L O P M E N T PolyOne Corporation 29 Leadership Program Participants 2012 2013 2015 47 86 2016 125 169 412 Campus Hires 2008 2011 2017 25 47 PolyOne LSS Blackbelts 2008 2011 67 247 147 2018 141 A U N I Q U E C U S T O M E R E X P E R I E N C E Industrial Design IQ DESIGN LABS PolyOne Corporation 30 Material & Color Expertise Manufacturing Expertise 3 14 Industrial designers $0 $10M $4M $80M Opportunity funnel New business revenue LSS CUSTOMER FIRST PolyOne Corporation 31 Customer Projects Enables sales growth by building more intimate customer relationships, giving us insight to customers’ needs, with a service that is not easily replicated 2 104 3 D P R I N T I N G B R I N G I N G N E W I D E A S T O L I F E PolyOne Corporation 32 Enables validation of fit and function Shortens design cycle and time to market Avoids tooling rework Drives innovation Delivers substantial customer value PolyOne Corporation 33 From concept to production 99.9% Reduction in turnaround time Traditional Timeline up to 24 weeks PolyOne ColorMatrix Select™ 6 hours Innovative system for processors and OEMs to develop colors in real time Complete system that provides customers with the freedom to match, prototype and produce color entirely within their own facility C O L O R M A T R I X S E L E C T ™ “Being able to create color and produce parts in 1 day is unheard of in this industry” -CEO, Industry Leader I N N O V A T I N G W I T H P O L Y O N E PolyOne Corporation 34 SEGMENT HIGHLIGHTS C O L O R , A D D I T I V E S & I N K S E N D M A R K E T S & S O L U T I O N S PolyOne Corporation 35 Solid Colorants Performance Screen Printing Inks Liquid Colorants 32% Textiles Wire & Cable Building & Construction 9%Consumer 7% Appliances Electrical & Electronics Operating Income & MarginRevenue by Region C O L O R , A D D I T I V E S & I N K S 2 0 1 8 R E V E N U E | O V E R $ 1 B I L L I O N $4 $25 $104 $159 0.9% 5.5% 12.2% 15.1% 8.0% 10.0% 12.0% 14.0% 16.0% 20 30 40 50 60 70 80 100 110 120 130 140 150 160 170 PolyOne Corporation 36 Europe 35% United States 45% Mexico South America S P E C I A L T Y E N G I N E E R E D M A T E R I A L S E N D M A R K E T S & S O L U T I O N S PolyOne Corporation 37 Engineered Formulations Advanced Thermoplastic Elastomers 28% 18% Electrical & Electronic Building & Construction 16% S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Revenue by Region Operating Income & Margin P R O F O R M A 2 0 1 8 R E V E N U E | $ 7 5 0 M I L L I O N * PolyOne Corporation 38 $21 $57 $72 0.1% 5.1% 9.3% 11.2% 8.0% 10.0% 12.0% 20 30 40 50 60 70 80 Europe 28% United States 46% 24% *Pro-Forma including Fiber-Line D I S T R I B U T I O N E N D M A R K E T S & S U P P L I E R S PolyOne Corporation 39 27% 23% 18% Electrical & Electronics Building & $20 $25 $63 $71 2.9% 5.9% 5.6% 1.0% 3.0% 5.0% 7.0% 15 25 35 45 55 65 75 Operating Income & Margin2018 Revenue | $1.3 Billion http://www.avient.com/Pages/VariationRoot.aspx O V E R V I E W O F R A W M A T E R I A L P U R C H A S E S PolyOne Corporation 40 Performance Polyethylene Pigments TiO2 Styrenic Block Copolymer 7% Nylon Polypropylene Plasticizers 4% Dyestuffs Other Raw Materials 32% $900 million of raw material purchases estimated in 2019 excluding Distribution business Note: All figures exclude PolyOne Distribution business and divested PP&S business T A R G E T E N D M A R K E T S & A P P L I C A T I O N E X A M P L E S PolyOne Corporation 41 Thermally Conductive Chemical Resistant Polymer Colorants Elastomeric Grips and Handles Structural Composites Antimicrobial Technologies Anti-Counterfeiting Target End Markets… Healthcare Catheter Technologies Under-hood Components Target End Markets… Automotive Interior Structural Sound & Vibration Management Roof Systems Air Management Electronics and Cameras Lighting Exterior / Interior Trim Braces & Brackets Fasteners Seals & Flaps Target End Markets… Consumer Thermally Conductive Polymer Colorants Elastomeric Grips and Handles Structural Composite Oxygen Scavenger Laser Marking Additives Antistatic Technologies UV Light Barrier Technologies Cap & Closure Colorants Process Optimization Antioxidant Technologies Density Modified Target End Markets… Packaging  Impart weight, sound and metallic finish to caps and closures for cosmetics and spirits applications  Elevate quality and prestige perceptions among high-end consumers  Eliminate time and cost associated with secondary operations and assembly Luxury Packaging GravitechTM Density Modified Polymers  Eliminate costs by increasing pigment density  Enhance color performance without altering form and formulation  Increase design capabilities by reducing weight and layer thickness Optimize Color Usage OnColorTM Super Concentrates  Inhibit microbial growth on polymer surfaces  Enhance value or products and devices  Highly versatile concentrate with the ability to be incorporated into a wide variety of products Combat Bacteria Formation WithStandTM Antimicrobial Technology  Durable, long-lasting products stand up to the most aggressive disinfectants  Minimize environmental stress cracking and discoloration  One of the broadest medically approved polymer and colorant portfolios Medical Device Housings Chemically Resistant Engineered Polymers Color & Design Services  Greater control of color development and supply chain  Work across entire design process from concept to commercialization  Inspire creativity in the use of polymer materials, colors, and effects  Innovative brand differentiation  Faster development timelines Outdoor Applications  Leading provider of high performance specialty materials for the recreational and sports & leisure industry  Well positioned across all segments to address market needs  Metal to Polymer Conversion  Lightweighting  Thermal Management  Impact Performance  ColorMatrix Fiber Colorant Solutions  Proprietary advanced liquid color formulations and equipment enable greater efficiency and productivity  Eliminates aqueous dyeing and its associated wastewater treatment  Solid Color Concentrates  Extrusion-spun fibers colored via solid masterbatch Fiber Colorants Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to PolyOne shareholders, excluding special items, to assess performance and facilitate comparability of results. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as alternatives to, financial measures prepared in accordance with GAAP.

For more information, visit https://www.avient.com.

For more information, visit https://www.avient.com.   

Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources. We also monitor earnings (defined as net income from continuing operations) before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA (EBITDA before the impact of special items) as a supplement to our GAAP measures. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as alternatives to, financial measures prepared in accordance with GAAP.

All auto-injector designs and renderings in this presentation were produced by Avient Design for conceptual purposes Avient Corporation 3 Focus on Patient Journey Self Management & Self Administration Technology Driven Monitoring & Diagnostics Increased Drug Volumes Large Molecule Biologics Faster Injections Trends Patient and drug development needs are evolving at a rapid pace. Smart health devices improve patient medication adherence and monitoring

Webcast Details The webcast can be viewed live at avient.com/investors, or by clicking here: https://edge.media- server.com/mmc/p/p4owuchb. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as alternatives to, financial measures prepared in accordance with GAAP. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as alternatives to, financial measures prepared in accordance with GAAP.